Quick ReadPlain-language overview · read this first
Tongcheng New Material is China's leading tire phenolic-resin producer, also carrying a growth curve in electronic chemicals such as semiconductor/display photoresists; current price RMB 62.88, market cap RMB 37.25 billion, rating Watch.
In 2025, revenue was RMB 3.429 billion and net profit attributable to the parent RMB 563 million; specialty rubber additives accounted for 67.9% and electronic chemicals 28.8%; it ranks first globally in tire-use phenolic resins and first in China by sales in semiconductor and TFT photoresists, with the founder holding a 60.82% controlling stake. The core tension is a valuation that front-runs future success and discounted profit quality: in 2024 associate earnings were 57% of total profit, and over 2020–2025 cumulative operating cash flow was only 56% of cumulative net profit attributable to the parent; adjusted PE is about 62x and PB about 8.6x, far above the CSI 300's 14.61x.
Three-scenario DCF gives conservative RMB 13–18, neutral RMB 20–28, and optimistic RMB 40–56, with an ideal buy zone of RMB 18–26, none of which the current price touches. An extreme scenario back to RMB 22–33 corresponds to a 45%–65% drawdown. Good company, bad price; wait for a margin of safety.
LeadTongcheng New Material combines a tire phenolic-resin cash cow with a growth curve in electronic chemicals such as photoresists. But at roughly 62x PE and 8.6x PB it has already priced in distant success, and its profits still lean on associate-company earnings, leaving no margin of safety. Rated Watch.
Prices in the article are as of publication; see the valuation band above for the live price.
Conclusion First
The bottom line up front: at present it is better suited to "Watch," rather than "buying outright as a value investor." Tongcheng New Material is not a bad company; on the contrary, it owns both a decent-quality mature business (specialty phenolic resins and additives for tires/rubber) and a high-potential growth business (electronic chemicals for semiconductors and display panels, especially photoresists, EBR, and CMP polishing pads). The real question is valuation, not narrative: the current share price has already priced in a good deal of distant success. As of May 20, 2026, the share price was about RMB 62.88, total market cap about RMB 37.25 billion, with Reuters/LSEG showing an adjusted PE of about 62.25x and PB of about 8.62x. For a company still expanding capacity, with unstable cash-flow conversion, and with a significant portion of profit still coming from investment income in associate companies, the margin of safety left for a conservative long-term investor is not enough.
| Item | Judgment |
|---|---|
| Investment rating | Watch |
| Core judgment | The company itself is high quality, but the price is expensive; "good company" and "good price" do not currently overlap |
| Is there a margin of safety at the current price | No |
| Suitable investor type | Better suited to growth / industry-trend investors willing to pay a high valuation for a domestic semiconductor-materials platform; not suited to conservative value investors who prioritize low valuation, strong cash flow, and a simple business model |
| Biggest uncertainty | Whether domestic substitution in electronic chemicals can keep ramping; whether the share of associate earnings in profit can fall while operating cash flow's share rises; whether subsequent refinancing / H-share progress dilutes returns |
State facts, inferences, and opinions separately. Fact: In 2025 the company's revenue was RMB 3.429 billion, net profit attributable to the parent RMB 563 million, and net operating cash flow RMB 338 million; within the 2025 operating data, specialty rubber additives and others generated RMB 2.320 billion, electronic chemicals RMB 986 million, and fully biodegradable materials RMB 113 million. Inference: The company is gradually shifting from "tire-resin leader + investment income" toward "mature cash cow + electronic-materials growth platform," but the transition is not yet complete. Opinion: If I were premising on a holding period of more than 10 years, with a "balanced-toward-conservative" risk appetite, I would care more about "cash-flow realization" and "purchase price," so I would be in no hurry to act now.
One-sentence conclusion: Tongcheng New Material is worth tracking for the long term, but at today's price it looks more like a "high-quality growth asset" than a "value stock with a margin of safety."
Understanding the Business
This company's core operations are not singular but comprise three parts: electronic chemicals, specialty materials for automobiles/tires, and fully biodegradable materials. On the 2025 operating-data basis, revenues from the three segments were about RMB 2.320 billion, RMB 986 million, and RMB 113 million respectively; by the author's calculation, the corresponding revenue shares were about 67.9%, 28.8%, and 3.3%. On the same basis in 2024, these three shares were about 74.7%, 22.8%, and 2.5%. This shows that the company's real change is a continuing tilt of the revenue mix toward electronic chemicals, not a surge in total revenue. In the 2026 first-quarter operating data, electronic-chemicals revenue already reached RMB 310 million, keeping its share at a high level.
Looking at "how it makes money," the mature business is easy to understand. Tire/rubber phenolic resins, additives, PTBP, and the like are essentially functional materials serving tire and rubber-products makers, earning money through shipment volume, formulation performance, quality stability, and long-term customer relationships. The company itself discloses that its phenolic resins are specialty rubber additives, used mainly to improve tire processing tack, the bonding strength of skeleton materials, and rubber mechanical strength; electronic chemicals cover semiconductor photoresists, display-panel photoresists, EBR, organic insulating films, luminescent materials, CMP polishing pads, and more. In other words, Tongcheng New Material today is striving to become a "traditional-chemicals cash cow + electronic-materials platform," rather than remaining just "a resin factory."
The customer structure is relatively dispersed, less fragile than certain semiconductor-materials companies that depend on a single large customer. Per the company's H-share application version, for FY2023, FY2024, and the first nine months of 2025, the company's customer counts were 610, 605, and 661 respectively; the revenue share of the top five customers was about 28.1%, 28.4%, and 29.9%, and the largest customer's share was about 11.3%, 11.7%, and 10.7%. This means the business is not "extremely concentrated," yet it also shows the company still has several key customers that determine its scale and bargaining room.
Revenue stability shows a "two-speed structure." The tire rubber-additives business has strong industrial-consumable characteristics but is affected by seasonal maintenance shutdowns in the tire industry; the company discloses that this segment is usually weaker in demand during July–August. Electronic chemicals and biodegradable materials have less pronounced seasonality, but electronic chemicals are more affected by validation cycles, customer-onboarding pace, and the progress of domestic substitution. The result is that the tire business is steadier, the electronics business is more growth-oriented but also harder to predict. For a long-term owner, this means the company is understandable, yet it is not the kind of exceptionally simple, transparent single good business.
On the cost structure, one of the core raw materials for tire chemicals is phenol. The company's annual report explicitly states that changes in raw-material prices affect operating costs "proportionally"; in 2025, the average purchase price of the main raw material phenol fell 13.16% YoY, while the average selling price of specialty rubber additives and other products fell 7.28% YoY, yet the average selling price of electronic chemicals rose 14.01% YoY. This shows: the tire-resin business is more of a "cost-plus + industry-game" industrial product, while the electronic-materials business has more potential pricing power.
If we use "would I still be willing to hold if the stock market closed for 5 years" as a test, my answer is: I would be willing to hold this business, but I would not rashly take a heavy position at today's price. The reason is simple: the business itself is not bad, especially the value of its leading position in tire resins and the growth option in electronic materials; but it is still some distance from a Buffett-style ideal: simple, stable, and cash-flow-rich. Business understandability score: 3.5/5.
Industry, Competitive Landscape, and Moat
On industry, Tongcheng New Material actually straddles three tracks with different rhythms. Tire/rubber additives is a mature industrial-materials industry: demand is relatively stable over the long run but grows slowly, closer to a "cyclical but not violent" mid-speed industry; electronic chemicals/photoresists is a growth track with policy support, high technical barriers, long validation cycles, and large room for domestic substitution; biodegradable materials has a policy theme, but demand and profitability are unstable. The company's 2025 annual-report summary also explicitly discusses these three as core business segments.
Whether long-term demand is stable requires a split answer. Tire chemicals are driven by vehicle ownership, tire-replacement demand, and demand for high-performance tires on new-energy vehicles, so demand has medium-to-long-term resilience; the company cites industry data that in 2025 China's total rubber-additive output grew 3.8% YoY and exports grew 7.71% YoY. Electronic chemicals depend more on domestic substitution and advanced-process capacity expansion; in both its 2024 and 2025 annual-report summaries, the company stresses that the importance of self-sufficient domestic supply of key semiconductor and display materials keeps rising.
In the competitive landscape, the most notable point is: the company is the leader in its most mature niche, but on the growth track the market values most, the moat is still forming. Per the company's H-share application version, in the first nine months of 2025 the company ranked first among Chinese suppliers by sales value in both the Chinese semiconductor-photoresist market and the Chinese TFT-array-photoresist market; in the global and Chinese market for tire-use phenolic-resin rubber additives, it also ranked first by sales value. The company's 2025 annual-report summary further states that the company has for many consecutive years been China's largest producer of rubber phenolic resins, reinforcing resins, and adhesive resins. That is to say, in the narrow, deep niche of tire phenolic resins the company's position is very strong; and in the domestic-substitution camp for semiconductor/display photoresists it has already moved to the front row.
But the main competitors are not just "the same one company." In the electronic-materials direction, A-share comparables include at least Shanghai Sinyang, Jingrui Electronic Material, and Nata Opto-electronic, which respectively focus on semiconductor process materials, photoresists and supporting materials, and precursors and electronic specialty gases. Reuters/LSEG pages show that Shanghai Sinyang is mainly engaged in R&D, production, and sales of semiconductor materials; Jingrui Electronic Material's products include photoresists and auxiliary materials, high-purity reagents, etc.; Nata Opto-electronic's main business is advanced precursors, electronic specialty gases, photoresists, and supporting materials. In other words, when the market values Tongcheng New Material, it often compares it with semiconductor-materials platform companies rather than with traditional resin factories.
The moat must be assessed item by item; no one-size-fits-all:
| Moat factor | Judgment | Basis |
|---|---|---|
| Brand advantage | Medium | Its brand is relatively strong among tire phenolic resins and among domestic display/semiconductor photoresist suppliers, but it is not an end-consumer brand |
| Cost advantage | Medium-to-strong | Multi-base production, partial upstream extension, and large scale in the mature business; stays profitable even amid raw-material swings |
| Scale advantage | Above industry average | Seven major production facilities; first in global/China sales value for tire-use phenolic resins; among the leaders in domestic photoresists by Chinese supplier |
| Network effect | Weak | This is materials manufacturing, not a platform network business |
| Switching cost | Stronger in electronic materials, medium in tire materials | Photoresist/EBR/CMP and the like involve validation and yield lock-in; tire additives have formulation stickiness but substitution is not impossible |
| Channel advantage | Medium | Mainly direct sales, with long-term relationships built with leading domestic and international customers |
| Patent/regulatory barriers | Stronger in electronic materials | The company stresses that its semiconductor photoresists have independent IP, with high purity, stability, and validation thresholds |
| Data advantage | Weak | Not a data-driven business model |
| Corporate culture/operating capability | Medium-to-strong | Started in trading and gradually built an R&D + manufacturing + sales platform; execution is not weak |
| Capital-allocation capability | Medium | Acquiring Beixu Electronics and Kehua Microelectronics has strategic logic; but continued expansion and refinancing/H-share progress also indicate high capital needs |
The above judgments rely mainly on the company's annual-report summaries, annual reports, and H-share application version.
My overall judgment on the moat is: the tire-resin business's moat is relatively stable, while the electronic-materials business's moat is widening but cannot yet be called "wide and deep." For a competitor to replicate the tire-phenolic-resin leadership takes time, customer trust, and formulation validation; but what really determines the valuation ceiling is electronic materials, and that part is for now more "first-mover validation advantage + a domestic-substitution window," still far from the absolute barriers of top-tier international materials companies. In an inflationary environment, the company's price increases in the tire-resin business lean toward cost pass-through and do not constitute strong pricing power; electronic chemicals, with higher validation thresholds, in theory have stronger pricing ability. In an economic downturn the company can still be profitable, but in 2021 rising raw-material and freight costs once cut net profit attributable to the parent by 20.44% YoY and non-GAAP net profit by 33.13%, showing that its earnings stability is not flawless. Industry attractiveness score: 3/5; moat strength score: 3/5.
Management and Capital Allocation
From the ownership structure, the alignment between management and shareholder interests is a plus. The H-share application version discloses that founder and chairwoman Zhang Ning is the company's controlling shareholder, directly holding about 837,500 A-shares and, through controlled entities, controlling about 374.7 million A-shares in total; on the disclosed basis, her controlled stake is about 60.82% of the A-shares. This means control is quite concentrated, and management does not have the typical short-sighted incentive problem of "salaried professional managers."
On the "honesty and rationality" dimension, several signals are fairly positive: annual reports over the years have all received a standard unqualified opinion audit report from Ernst & Young Hua Ming; the 2025 internal-control evaluation report states that internal controls are effective; the 2025 audit-committee report also states that no material accounting errors, fraud, malpractice, or material misstatements were found. For a materials company with multiple businesses across many plants and subsidiaries, this at least shows that the financial-compliance baseline currently looks solid.
On capital allocation, the company's approach is clear: use the mature business and capital-market tools to incubate an electronic-materials platform. This path itself is not wrong. The company gradually took control of Beixu Electronics, Kehua Microelectronics, and others, expanding into display photoresists and semiconductor photoresists; it also built the Shanghai Chemical Industry Park photoresist and high-purity reagent project, the Changzhou CMP polishing-pad project, the Qianjiang positive-photoresist line, and more. The 2025 annual-report summary further discloses that G5-grade EBR has achieved scaled supply to leading domestic advanced semiconductor chip makers, and that the Changzhou CMP project's design capacity at full production is 250,000 pieces per year. From an industrial-logic standpoint, these allocations make sense.
But from a conservative shareholder's viewpoint, capital allocation also has clear costs. First, the company is not a "capital-light compounding machine" but a platform company that keeps expanding capacity and investing. Second, the company has no clear record of large-scale buybacks at significant undervaluation; it relies more on a combination of dividends + equity incentives + convertible bonds + potential H-share financing. Third, in 2026 the company has advanced matters related to an H-share listing, which means management still wants more capital ammunition; for existing shareholders this is both a growth opportunity and a sign that future per-share returns may not naturally benefit from scale expansion.
On the dividend record, payout intensity in recent years is not bad: for FY2023 the proposed dividend was RMB 5.90 per 10 shares, for FY2024 RMB 5.00 per 10 shares, and for FY2025 RMB 5.00 per 10 shares. This shows management does not entirely fail to reward shareholders; but for a Buffett-style investor, what truly matters is growth in per-share intrinsic value, not the absolute dividend amount. If there are enough high-ROIC reinvestment opportunities, lower dividends are reasonable; if reinvestment requires continuous financing while free cash flow cannot keep up, high dividends cannot mask capital-efficiency problems. Management and capital-allocation score: 3/5.
Financial Quality and Owner Earnings
First, the core financial trajectory. Based on the company's 2020–2025 annual reports and summaries, from 2020 to 2025 revenue compounded at about 10.9%, net profit attributable to the parent at about 6.5%, and net operating cash flow at about 10.3%; but more crucially, over the six years 2020–2025 cumulative operating cash flow was only about 56% of cumulative net profit attributable to the parent. This is not "unacceptable," but it certainly cannot be called high-quality cash conversion.
The table below is compiled from the company's 2020–2025 annual reports and summaries, in RMB 100 million; net margin and cash-conversion ratio are the author's calculations.
| Year | Revenue | Net profit attrib. to parent | Net operating cash flow | Net margin | Operating CF / net profit |
|---|---|---|---|---|---|
| 2020 | 20.46 | 4.10 | 2.07 | 20.1% | 0.50 |
| 2021 | 23.08 | 3.27 | 3.45 | 14.1% | 1.06 |
| 2022 | 25.00 | 2.98 | 1.03 | 11.9% | 0.34 |
| 2023 | 29.44 | 4.07 | 1.84 | 13.8% | 0.45 |
| 2024 | 32.70 | 5.17 | 2.43 | 15.8% | 0.47 |
| 2025 | 34.29 | 5.63 | 3.38 | 16.4% | 0.60 |
If we look only at the income statement, the trend is actually good: after bottoming in 2022, 2023–2025 showed continuous recovery; in 2025 revenue grew 4.85% YoY, net profit attributable to the parent grew 8.86% YoY, non-GAAP net profit grew 29.58% YoY, operating cash flow grew 39.42% YoY, and ROE rose from 12.62% to 15.98%. On the surface of the statements, the company looks like it is improving.
But from the standpoint of "profit quality," one often-overlooked fact must be pointed out: investment income from associate companies contributes greatly to profit. In the H-share application version, in 2024 the company's share of associate-company profit was RMB 314.39 million, while the company's total profit that year was RMB 550.17 million; the author accordingly calculates that associate earnings accounted for about 57% of total profit. In the first nine months of 2025, this share of associate-company profit was still RMB 329.63 million. Combined with the company's earlier disclosed equity investment in Zhongce Rubber, this means that part of the profit on Tongcheng New Material's statements comes from equity-method gains from held high-quality tire assets, rather than from "recovering cash after selling its own manufactured materials to customers." This is not a bad thing, but for Owner Earnings it should be discounted noticeably versus profit that "comes entirely from operating one's own business."
This is also why I lean toward the view that the company's profit is real profit, but it is not entirely equivalent to high-quality, freely distributable cash profit. On the one hand, the company has a real industrial position and real growth; on the other, the company keeps expanding capacity, validating, and onboarding customers, which requires investment in capacity and working capital, while associate earnings are inherently not 100% currently distributable cash. In other words, net-profit quality is higher than that of story companies but lower than that of a typical free-cash-flow machine.
Regarding gross margin, operating margin, ROIC, net debt/EBITDA, interest coverage, etc., the publicly searchable summaries cannot fully cover all notes to the 2025 full text, so only cautious judgments are possible. On the known basis, the 2023–2024 consolidated gross margin rose from roughly 23.7%–24.8%; in 2025, with electronic-chemicals average selling prices continuing to rise and raw-material phenol continuing to fall, margins most likely did not deteriorate. In 2024, financial expenses were RMB 68 million and total profit RMB 550 million; roughly estimating EBIT as "total profit + financial expenses," interest coverage is not fragile; moreover, in 2025 the company completed conversion of its convertible bonds, so in theory interest pressure eased further. However, because the full notes to the 2025 report were not fully retrieved, precise net debt/EBITDA, interest coverage, and capex intensity should still be treated as "needing the full text" rather than precisely confirmed.
Owner-Earnings Estimate
I lean toward a conservative estimate rather than mechanically treating net profit as Owner Earnings. The estimation logic is as follows: First, use 2025 net profit attributable to the parent of RMB 563 million as the starting point; second, referencing the company's 2024 depreciation and amortization of RMB 167 million and the first-nine-months-2025 D&A of RMB 151 million, after annualizing I roughly estimate 2025 D&A at RMB 190–210 million; third, considering the company is still in an expansion phase, maintenance capex cannot be counted as zero, so I use a range of RMB 130–180 million; fourth, considering working capital will still tie up cash over the long term, I conservatively deduct RMB 50–120 million. Based on these assumptions, I give a conservative range for 2025 Owner Earnings of about RMB 450–600 million, with a neutral value of about RMB 520 million. This is an estimate, not a value the company directly discloses.
Under this range, on a market cap of about RMB 37.25 billion as of May 20, 2026, the current share price corresponds to an Owner-Earnings multiple of about 62–83x, with a neutral value of about 72x. For a company still heavily investing, with unstable cash flow, and with part of its profit dependent on associate earnings, that is clearly not cheap. Therefore I believe: free cash flow and Owner Earnings are more likely to be lower than or close to net profit over the long term, rather than persistently higher than net profit.
Valuation, Margin of Safety, and Opportunity Comparison
Owner-Earnings Discount Method
I use three scenarios for the discount, all expressed as "intrinsic value per share," all author estimates:
| Scenario | Starting Owner Earnings | Growth over next 10 years | Discount rate | Terminal growth | Estimated intrinsic value |
|---|---|---|---|---|---|
| Conservative | RMB 450 million | 6% | 10% | 3% | about RMB 13–18/share |
| Neutral | RMB 520 million | 10% | 10% | 3% | about RMB 20–28/share |
| Optimistic | RMB 600–650 million | 15% | 8%–9% | 3% | about RMB 40–56/share |
Unless you view the company as a "quasi-core asset" that can compound at a very high rate for the next 10 years with capex pressure on cash flow rapidly declining, DCF struggles to support the current price of RMB 62.88. Even in the optimistic scenario, the result only barely approaches or is still below the current price.
Relative Valuation Method
On relative valuation, Tongcheng New Material looks a bit "deceptive": if you compare it with pure semiconductor-materials companies, its PE is not the most expensive; but if you compare it with its own cash-realization ability and with the broader A-share benchmark, it is clearly not cheap. Reuters/LSEG show Tongcheng New Material's current adjusted PE at about 62.25x and PB at about 8.62x; Shanghai Sinyang about 91.23x PE and 6.73x PB; Jingrui Electronic Material about 154.93x PE and 6.58x PB. Meanwhile, Lixinger shows the CSI 300's current market-cap-weighted PE at about 14.61x. My reading: Tongcheng New Material is indeed more "substantial" than some pure-concept semiconductor-materials stocks, but relative to the CSI 300 and to its own mature-business character, it is still expensive.
The table below lists only the most useful comparable metrics. Because EV/EBITDA requires the latest complete debt and cash figures, and the public search summaries are incomplete, I do not force a pseudo-precise number.
| Name | Adjusted PE | PB | ROE/ROI reference | Note |
|---|---|---|---|---|
| Tongcheng New Material | 62.25x | 8.62x | ROE about 6.50 (Reuters mid-basis) | Hybrid: tire chemicals + electronic materials |
| Shanghai Sinyang | 91.23x | 6.73x | ROE about 5.66 | More of a pure semiconductor-materials platform |
| Jingrui Electronic Material | 154.93x | 6.58x | ROE about 2.91 | Extremely high valuation, somewhat weaker earnings quality |
| CSI 300 | 14.61x | — | Corresponding earnings yield about 6.8% | Broad benchmark |
This table shows two things. First, the market prices Tongcheng New Material's electronic-materials imagination space very highly. Second, its PB is even higher than some semiconductor-materials comparables, showing the market has given not only a growth premium but also a relatively high asset premium. For a conservative investor, this is not a comfortable starting point.
Asset-Value Method
The asset method struggles to support the current price. In 2025, net assets attributable to the parent were about RMB 4.186 billion; at the current market cap, the price-to-book is close to 9x; even at Reuters/LSEG's PB of about 8.62x, it is still far above the level of a typical manufacturing value stock. The company does have some "hidden assets": as of end-2024, on-balance-sheet investments in associate companies were about RMB 2.131 billion, and Prinx Chengshan shares within trading financial assets were about RMB 144 million. But even giving these assets a reasonable premium, the asset method's result is more of a "reference for downside protection" than a core basis for supporting a share price above RMB 60.
Combining the three methods, my conclusion is:
| Valuation range | Price range |
|---|---|
| Conservative intrinsic-value range | RMB 15–22/share |
| Fair intrinsic-value range | RMB 22–35/share |
| Optimistic intrinsic-value range | RMB 35–50/share |
| Ideal buy-price range | RMB 18–26/share |
| Acceptable holding-price range | RMB 26–38/share |
| Clearly overvalued price range | above RMB 45–50/share |
Under this framework, RMB 62.88 corresponds to a price that is significantly above fair value and not cheap even against the optimistic value.
Margin of Safety and Opportunity Comparison
The biggest problem with the current price is valuation fragility, not business quality: there are too many fragile assumptions embedded in the valuation. You need to believe electronic chemicals will keep growing fast, gross margins will keep rising, associate earnings are not a profit illusion, expansion projects will successfully convert into per-share free cash flow, and refinancing will not significantly dilute. If any single link falls short of expectations, the current valuation lacks a cushion.
Compared with the index, I do not think it is clearly better than buying the CSI 300. The reason is direct: the CSI 300's current PE is about 14.61x with an earnings yield of about 6.8%; while Tongcheng New Material's current adjusted PE is about 62x with an earnings yield of about 1.6%. Buying Tongcheng is buying "the realization of high growth over a fairly long future period," rather than "already-realized cash returns." For a balanced-toward-conservative investor, these odds are not good. As for comparison with high-grade bonds, Reuters reports that in April 2026 China's 30-year special treasury bond was issued at a rate of about 2.20%; Tongcheng New Material of course has higher long-term return potential, but considering the current valuation and execution risk, its risk compensation does not appear ample.
My judgment is: it is now more worthwhile to wait for a better price than to rush in. This is the classic case of "good company, bad price."
Risks, Checklist, and Final Judgment
For the most important risks, I rank them by "permanent capital loss" rather than short-term volatility. First is valuation risk: the current price already over-discounts a lot of future success, and multiple contraction alone is enough to cause a sizable loss. Second is growth-realization risk: electronic chemicals are the main source of the high valuation, but validation, ramp-up, yield, and customer penetration in this segment all take time. Third is profit-quality risk: associate-company earnings contribute greatly to profit, while operating cash flow's coverage of net profit is not high over the long term. Fourth is capex and financing risk: if the electronic-materials platform keeps expanding, it will need more capital, and H-share progress or other refinancing may depress per-share returns. Fifth is industrial-product-nature risk: the tire-resin business is still affected by raw-material prices, tire-industry conditions, and customer maintenance cycles, and is not a business fully immune to cycles.
The strongest counter-view is actually very compelling: the market may be overestimating the speed at which the "electronic-materials story" transforms the whole company. In 2025, about 68% of revenue still came from specialty rubber additives and others; at the same time, in 2024, about 57% of total profit came from associate-company earnings. In other words, if you view it as a "pure photoresist leader," you have probably already erred on the business structure; and if you add on operating cash flow being persistently below net profit, then the so-called "high growth, high valuation" could turn into a dangerous combination of "non-cash profit + high capex + high valuation."
Which facts, if they appear, would make me admit I was wrong and reassess? First, the electronic-chemicals revenue share continues to rise to 35%–40% over the next two to three years, not by trading price for volume but through stable ramp-up after validation passes; second, the share of associate earnings in profit falls noticeably, with core operating profit and operating cash flow becoming dominant; third, operating cash flow / net profit rises stably to above 80% in the medium term; fourth, the return on capital corresponding to H-share or subsequent financing is clearly above the cost of capital. Conversely, if electronic-materials ramp-up falls short, associate earnings still dominate net profit, and cash conversion stays weak, then I would more firmly conclude the market has mispriced it.
Investment Checklist
| Check item | Judgment |
|---|---|
| Can I understand this business | Pass |
| Does it have long-term stable demand | Pass |
| Does it have a durable moat | Uncertain |
| Does it have pricing power | Partial pass |
| Can it generate stable free cash flow | Fail |
| Is its return on capital excellent | Partial pass |
| Is management trustworthy | Pass |
| Is capital allocation rational | Partial pass |
| Is the balance sheet sound | Uncertain |
| Is the valuation below intrinsic value | Fail |
| Is the margin of safety sufficient | Fail |
| Does long-term holding put me at ease | The price is not reassuring, but the business itself is decent |
| Which key facts would make me sell | Electronic-materials ramp-up fails; cash flow stays persistently poor; refinancing returns miss targets; over-reliance on associate earnings |
| Am I only wanting to buy because of the rising price or market sentiment | Very likely need to guard against this impulse |
Final Investment Conclusion
【Final Rating】 Watch
【One-sentence investment thesis】 Tongcheng New Material has a very strong mature leading business and an imaginative electronic-materials growth curve, but the current price has already bought in a lot of future success.
【Core bull points】
The company holds a strong position in the tire-use phenolic-resin/rubber-additives niche, ranking near the top by sales value in relevant global and China niche markets.
The electronic-chemicals revenue share keeps rising, reaching close to 29% in 2025, with the business mix optimizing toward high growth.
Product lines such as semiconductor photoresists, display-panel photoresists, G5-grade EBR, and CMP polishing pads form a platform-style layout, with customer-validation barriers higher than for traditional industrial products.
The founder has strong control, and the audit and internal-control records are currently fairly clean.
2023–2025 results and ROE are overall in a recovery range.
【Core bear points】
The current valuation is too high: as of May 20, 2026, adjusted PE is about 62x and PB about 8.6x.
Over the six years 2020–2025, cumulative operating cash flow was only about 56% of cumulative net profit attributable to the parent; cash-flow quality is not strong enough.
In 2024, associate-company earnings were about RMB 314 million, about 57% of that year's total profit; profit is not mainly driven by core operating cash flow.
In 2025, about 68% of revenue still came from specialty rubber additives and others; if the market prices it as a "pure electronic-materials leader," there is a mismatch.
H-share progress and continued expansion mean future capital needs remain high, which may suppress per-share returns.
【Key assumptions】
Electronic chemicals maintain growth clearly above the company's overall rate over the next 5–10 years;
Customer validation for photoresists/EBR/CMP and the like keeps advancing, and not at the expense of margins;
Reliance on associate earnings falls, and operating cash flow's coverage of net profit rises;
The return on expansion and financing projects is above the cost of capital.
【Fair Buy Price】 RMB 18–26/share. Basis: the conservative and neutral DCF ranges, cross-validated after relative valuation reverts toward 25–35x PE / 4–6x PB.
【Target holding period】 If the price enters the fair range in the future, holding with a 5–10-year horizon is recommended; at the current price, it is not advisable to ignore valuation with a "hold-forever" mindset.
【Expected annualized return】 A rough estimate based on the current price:
Conservative scenario: -5% to -3%/year;
Neutral scenario: 2% to 4%/year;
Optimistic scenario: 9% to 11%/year. These estimates assume Owner Earnings grow at 6%/10%/15% respectively over the next 10 years, with terminal multiples of 25x/30x/35x, carrying obvious model uncertainty.
【Maximum loss risk】 If electronic-materials ramp-up falls short of expectations, associate earnings decline, and the market re-prices it as a "mature specialty-chemicals + investment-income stock" rather than a "high-growth electronic-materials platform," it is not hard to imagine the share price returning to RMB 22–33, corresponding to a drop of about 45%–65% from the current price; in more extreme cases, if the growth logic is frustrated and valuation reverts to the conservative range, a fall to RMB 15–20 is not impossible either.
【Tracking indicators】
Electronic-chemicals revenue share;
Progress of photoresist, EBR, and CMP polishing-pad validation-to-mass-production;
The ratio of operating cash flow to net profit attributable to the parent;
The proportion of associate earnings in total profit;
Whether inventory and accounts-receivable growth outpaces revenue;
Capex and utilization of new capacity;
H-share/other financing progress and use of proceeds;
Whether dividend and buyback policy centers on per-share value;
Whether the tire-resin business's gross margin can stabilize;
Changes in electronic-materials average selling prices and customer structure.
【Signals that trigger reassessment】
Electronic chemicals grow below expectations for several consecutive quarters;
Operating cash flow again falls clearly below net profit;
Refinancing is large in scale but project returns are unclear;
Key-customer validation fails or the pace of import substitution slows;
A decline in associate earnings materially pressures profit.
【Final recommendation】 Coolly put, Tongcheng New Material is worth studying and worth keeping on the watchlist for the long term, but it is not worth overpaying for "because it's a good company" without a margin of safety. For a long-term business owner, the real question is whether, if I buy equity in this company today, the real cash return I receive over the next 10 years will be high enough and certain enough, more than whether it "will keep rising." Based on current information, my answer is: the company can continue to be tracked; please wait patiently on price.
Open questions and limitations This report primarily used the company's 2025 annual-report summary, the 2024/2023/2021/2020 annual reports, the 2025 key-operating-data announcement, the 2026 first-quarter key-operating-data announcement, the H-share application version, and Reuters/LSEG current market data. Because the searchable text of the full 2025 annual report is incomplete, items such as precise 2025 capex, precise net debt/EBITDA, precise interest coverage, and a complete 2026Q1 balance sheet are explicitly marked in the text as "estimates" or "needing the full text," and these estimates should not be taken as data the company directly discloses.
This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.
Full report
Sign in to read the full report
Sign up free to unlock the full text, the Baillie growth scorecard, and full-text search.
Log in / Sign up free